Table 2.

ACTIVATE protocol schedule of forms and procedures

Procedures	Screening	Baseline/randomisation	7 days postrandomisation*	Trial intervention†	26 weeks postrandomisation	27 weeks postrandomisation*	52 weeks postrandomisation	53 weeks postrandomisation*
Eligibility screening and consent
Assessment of eligibility	X
Informed consent	X
Confirm consent		X		X	X		X
Randomisation		X
Vital signs, height, weight, serum cholesterol		X
Outcome measurement
Seattle Angina Questionnaire		X			X		X
MRC dyspnoea scale		X			X		X
Hospital Anxiety and Depression Scale		X			X		X
General Self-Efficacy scale		X			X		X
EQ-5D-5L		X			X		X
Client Service Receipt Inventory		X			X		X
Physical activity measured with ActivPal accelerometer		X	X*		X	X*	X	X*
International Physical Activity Questionnaire			X			X		X
Incremental shuttle walk test		X			X		X
Safety event reporting
Monitoring of adverse events			X	X	X	X	X	X
Monitoring of serious adverse events			X	X	X	X	X	X

*Removal of ActivPal after 7 days.

†If randomised to intervention arm, participants will be invited to meet with member of cardiac rehabilitation staff who will train the participant on how to use the intervention.

EQ-5D-5L, EuroQol-5 Dimensions-5 Levels.